
Extra: Why Is 23andMe Going Under? (Update)
Freakonomics Radio
The Rise and Fall of 23andMe
This chapter explores the trajectory of 23andMe, highlighting its initial success and subsequent struggles in the competitive genetics market. It examines key challenges such as monetizing wellness products, the impact of a recent data breach, and the company's pivot towards private ownership amidst financial pressures. The discussion underscores the potential of 23andMe's data while questioning the feasibility of its business model and future innovation in drug discovery.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.